Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Iron Hydroxide Adipate Tartrate
Therapeutic Area : Hematology
Study Phase : Approved
Sponsor : Nemysis
Deal Size : Undisclosed
Deal Type : Agreement
Nemysis Limited Signs with Kolinpharma SpA an IHAT Sales and Marketing Agreement
Details : Kolinpharma will market Iron Hydroxide Adipate Tartrate (IHAT), an oral iron supplement for iron deficiency, utilizing its existing sales network under the brand KIPFeR.
Brand Name : KIPFeR
Molecule Type : Small molecule
Upfront Cash : Undisclosed
January 10, 2024
Lead Product(s) : Iron Hydroxide Adipate Tartrate
Therapeutic Area : Hematology
Highest Development Status : Approved
Sponsor : Nemysis
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?